| 175 | Humans |
| 110 | Female |
| 105 | Male |
| 60 | Middle Aged |
| 57 | Aged |
| 50 | Adult |
| 33 | Aged, 80 and over |
| 29 | Animals |
| 27 | Young Adult |
| 24 | Treatment Outcome |
| 21 | Adolescent |
| 20 | Risk Factors |
| 20 | Child |
| 18 | United States |
| 15 | Prospective Studies |
| 14 | Case-Control Studies |
| 12 | Polymorphism, Single Nucleotide |
| 12 | Genome-Wide Association Study |
| 12 | Genetic Predisposition to Disease |
| 12 | Cohort Studies |
| 11 | Retrospective Studies |
| 11 | Mice |
| 10 | Genotype |
| 9 | Time Factors |
| 9 | Magnetic Resonance Imaging |
| 9 | Follow-Up Studies |
| 9 | Child, Preschool |
| 9 | Canada |
| 8 | Survival Rate |
| 8 | Randomized Controlled Trials as Topic |
| 8 | Phenotype |
| 8 | Disease Models, Animal |
| 8 | Cross-Sectional Studies |
| 8 | Brain |
| 7 | Prognosis |
| 7 | Longitudinal Studies |
| 7 | Infant |
| 7 | Depressive Disorder, Major |
| 7 | Comorbidity |
| 7 | Bipolar Disorder |
| 6 | Reproducibility of Results |
| 6 | Neoplasm Staging |
| 6 | Mutation |
| 6 | Molecular Sequence Data |
| 6 | Infant, Newborn |
| 6 | Incidence |
| 6 | Gene Expression Profiling |
| 6 | Double-Blind Method |
| 6 | Cell Line, Tumor |
| 6 | Amino Acid Sequence |
| 6 | Age Factors |
| 5 | Severity of Illness Index |
| 5 | Sequence Analysis, DNA |
| 5 | Pedigree |
| 5 | Outcome Assessment (Health Care) |
| 5 | Out-of-Hospital Cardiac Arrest |
| 5 | HIV Infections |
| 5 | European Continental Ancestry Group |
| 5 | Endovascular Procedures |
| 5 | Cerebral Cortex |
| 5 | Aging |
| 4 | White Matter |
| 4 | Tomography, X-Ray Computed |
| 4 | Tissue Plasminogen Activator |
| 4 | Survival Analysis |
| 4 | Stroke |
| 4 | Societies, Medical |
| 4 | Serotonin Uptake Inhibitors |
| 4 | Sequence Alignment |
| 4 | Resuscitation |
| 4 | Registries |
| 4 | Psychiatric Status Rating Scales |
| 4 | Pregnancy |
| 4 | Postoperative Complications |
| 4 | Neural Pathways |
| 4 | Mice, Inbred C57BL |
| 4 | Logistic Models |
| 4 | Liver |
| 4 | Kidney |
| 4 | HEK293 Cells |
| 4 | Genetic Variation |
| 4 | Fibrinolytic Agents |
| 4 | Evidence-Based Medicine |
| 4 | Europe |
| 4 | Drug Therapy, Combination |
| 4 | Decision Making |
| 4 | Cost-Benefit Analysis |
| 4 | Consensus |
| 4 | Computer Simulation |
| 4 | Computational Biology |
| 4 | Colorectal Neoplasms |
| 4 | Cognition Disorders |
| 4 | Clinical Trials as Topic |
| 4 | Cell Proliferation |
| 4 | Cardiopulmonary Resuscitation |
| 4 | Biomarkers |
| 4 | Anti-HIV Agents |
| 4 | Alleles |
| 4 | Algorithms |
| 4 | Activities of Daily Living |
| 3 | Terminology as Topic |
| 3 | Signal Transduction |
| 3 | Sertraline |
| 3 | Sensitivity and Specificity |
| 3 | Research Design |
| 3 | Renal Dialysis |
| 3 | Recognition (Psychology) |
| 3 | Rats |
| 3 | RNA Interference |
| 3 | Quality of Life |
| 3 | Prevalence |
| 3 | Predictive Value of Tests |
| 3 | Practice Guidelines as Topic |
| 3 | Physicians |
| 3 | Phosphorylation |
| 3 | Pancreatic Neoplasms |
| 3 | Mutation, Missense |
| 3 | Multivariate Analysis |
| 3 | Models, Statistical |
| 3 | Models, Neurological |
| 3 | Models, Molecular |
| 3 | Melanoma |
| 3 | Lupus Erythematosus, Systemic |
| 3 | Linear Models |
| 3 | Internship and Residency |
| 3 | Internet |
| 3 | Internationality |
| 3 | Insulin |
| 3 | Immunohistochemistry |
| 3 | Hematopoietic Stem Cell Transplantation |
| 3 | Graft Rejection |
| 3 | Genetic Loci |
| 3 | Genetic Association Studies |
| 3 | Gait |
| 3 | Fatigue |
| 3 | Exome |
| 3 | Drug Resistance, Neoplasm |
| 3 | Diffusion Tensor Imaging |
| 3 | DNA Damage |
| 3 | DNA Copy Number Variations |
| 3 | Critical Illness |
| 3 | Critical Care |
| 3 | Congresses as Topic |
| 3 | Combined Modality Therapy |
| 3 | Cognition |
| 3 | Clinical Competence |
| 3 | Carcinoma, Squamous Cell |
| 3 | Body Mass Index |
| 3 | Biomarkers, Tumor |
| 3 | Benzodiazepines |
| 3 | Anxiety |
| 3 | Anxiety Disorders |
| 3 | Antipsychotic Agents |
| 3 | Antineoplastic Agents |
| 3 | Antidepressive Agents |
| 3 | Alzheimer Disease |
| 3 | Age of Onset |
| 3 | Adenosine Triphosphate |
| 2 | gamma-Aminobutyric Acid |
| 2 | Zebrafish |
| 2 | Xenograft Model Antitumor Assays |
| 2 | World Health Organization |
| 2 | Warfarin |
| 2 | Walking |
| 2 | Viral Load |
| 2 | Vasopressins |
| 2 | Vasoconstrictor Agents |
| 2 | Vaccines |
| 2 | Unrelated Donors |
| 2 | Transfection |
| 2 | Transcription, Genetic |
| 2 | Transcription Factors |
| 2 | Tissue Donors |
| 2 | Thrombolytic Therapy |
| 2 | Tendons |
| 2 | Surveys and Questionnaires |
| 2 | Sodium Channel Blockers |
| 2 | Social Behavior |
| 2 | Smoking |
| 2 | Skull Base Neoplasms |
| 2 | Skin Neoplasms |
| 2 | Self Concept |
| 2 | Schizophrenia |
| 2 | Salivary Gland Neoplasms |
| 2 | Robotic Surgical Procedures |
| 2 | Risk |
| 2 | Risk Assessment |
| 2 | Reward |
| 2 | Repetition Priming |
| 2 | Remission Induction |
| 2 | Receptors, Opioid, mu |
| 2 | Real-Time Polymerase Chain Reaction |
| 2 | Reactive Oxygen Species |
| 2 | Rats, Sprague-Dawley |
| 2 | ROC Curve |
| 2 | RNA, Small Interfering |
| 2 | Quality of Health Care |
| 2 | Quality Improvement |
| 2 | Psychotic Disorders |
| 2 | Protein Transport |
| 2 | Protein Interaction Domains and Motifs |
| 2 | Protein Conformation |
| 2 | Protein Binding |
| 2 | Prosthesis Design |
| 2 | Proportional Hazards Models |
| 2 | Placebos |
| 2 | Phenylketonurias |
| 2 | Peptide Fragments |
| 2 | Pennsylvania |
| 2 | Pediatrics |
| 2 | Parent-Child Relations |
| 2 | Ovarian Neoplasms |
| 2 | Osteoporosis |
| 2 | North America |
| 2 | Neuropsychological Tests |
| 2 | Neurons |
| 2 | Neoplasms |
| 2 | National Institutes of Health (U.S.) |
| 2 | Models, Genetic |
| 2 | Mobility Limitation |
| 2 | Mitochondria |
| 2 | Microsatellite Repeats |
| 2 | Mice, Knockout |
| 2 | Lung Neoplasms |
| 2 | Lipid Peroxides |
| 2 | Kidney Transplantation |
| 2 | Kidney Failure, Chronic |
| 2 | Kaplan-Meier Estimate |
| 2 | Intraocular Pressure |
| 2 | Internal Medicine |
| 2 | Insulin-Secreting Cells |
| 2 | Information Dissemination |
| 2 | High-Throughput Nucleotide Sequencing |
| 2 | Hematologic Neoplasms |
| 2 | Heart Failure |
| 2 | Heart Defects, Congenital |
| 2 | Health Status |
| 2 | Guidelines as Topic |
| 2 | Gray Matter |
| 2 | Glomerular Filtration Rate |
| 2 | Glaucoma |
| 2 | Geriatric Assessment |
| 2 | Gene Expression Regulation, Developmental |
| 2 | Gene Deletion |
| 2 | GABAergic Neurons |
| 2 | Frail Elderly |
| 2 | Fractures, Bone |
| 2 | Forecasting |
| 2 | Football |
| 2 | Fluid Therapy |
| 2 | Feasibility Studies |
| 2 | Exons |
| 2 | Exercise Therapy |
| 2 | Exercise Test |
| 2 | Executive Function |
| 2 | Ethnic Groups |
| 2 | Epinephrine |
| 2 | Energy Metabolism |
| 2 | Employment |
| 2 | Embryonic Stem Cells |
| 2 | Educational Status |
| 2 | Dose-Response Relationship, Drug |
| 2 | Disease-Free Survival |
| 2 | Disease Progression |
| 2 | Diet |
| 2 | Diagnostic Imaging |
| 2 | Diagnostic Errors |
| 2 | Diabetes Mellitus, Type 1 |
| 2 | Desensitization, Immunologic |
| 2 | Depression |
| 2 | Delphi Technique |
| 2 | Datasets as Topic |
| 2 | Data Interpretation, Statistical |
| 2 | Data Collection |
| 2 | DNA |
| 2 | DNA Repair |
| 2 | DNA Mutational Analysis |
| 2 | Coronary Angiography |
| 2 | Connectome |
| 2 | Complement C1q |
| 2 | Citalopram |
| 2 | Cell Differentiation |
| 2 | Carcinoma, Non-Small-Cell Lung |
| 2 | Bronchoalveolar Lavage Fluid |
| 2 | Breast Neoplasms |
| 2 | Brain Stem |
| 2 | Brain Diseases |
| 2 | Blood Pressure |
| 2 | Biopterin |
| 2 | Biomedical Research |
| 2 | Biological Evolution |
| 2 | Base Sequence |
| 2 | Autoimmunity |
| 2 | Autoantibodies |
| 2 | Autistic Disorder |
| 2 | Attention |
| 2 | Arthritis, Rheumatoid |
| 2 | Arterial Occlusive Diseases |
| 2 | Antibodies, Monoclonal |
| 2 | Anterior Cruciate Ligament |
| 2 | Anterior Cruciate Ligament Reconstruction |
| 2 | Anisotropy |
| 2 | Analgesics, Opioid |
| 2 | Aldehydes |
| 2 | African Americans |
| 2 | Adenocarcinoma |
| 2 | Acute Disease |
| 2 | Accidental Falls |
| 1 | beta-Galactosidase |
| 1 | alpha-Synuclein |
| 1 | Y-Box-Binding Protein 1 |
| 1 | Y Chromosome |
| 1 | X-Ray Microtomography |
| 1 | X-Ray Film |
| 1 | X Chromosome |
| 1 | Wounds, Stab |
| 1 | Workflow |
| 1 | Women's Health |
| 1 | Women's Health Services |
| 1 | Withholding Treatment |
| 1 | Weight Gain |
| 1 | Weaning |
| 1 | Water-Electrolyte Imbalance |
| 1 | Waist Circumference |
| 1 | Voltage-Gated Sodium Channels |
| 1 | Virus Replication |
| 1 | Virulence |
| 1 | Vesicular Transport Proteins |
| 1 | Vertebral Artery |
| 1 | Venlafaxine Hydrochloride |
| 1 | Vegetables |
| 1 | Vascular Surgical Procedures |
| 1 | Valine |
| 1 | Vagus Nerve Stimulation |
| 1 | Vaccinia virus |
| 1 | Uterine Cervical Neoplasms |
| 1 | User-Computer Interface |
| 1 | Urology |
| 1 | Up-Regulation |
| 1 | United States Food and Drug Administration |
| 1 | Tyrosine |
| 1 | Tumor Suppressor Protein p53 |
| 1 | Tumor Burden |
| 1 | Trophoblasts |
| 1 | Triglycerides |
| 1 | Transport Vesicles |
| 1 | Transplantation, Homologous |
| 1 | Transplantation, Autologous |
| 1 | Transplantation Conditioning |
| 1 | Translational Medical Research |
| 1 | Transfusion Medicine |
| 1 | Transforming Growth Factor beta |
| 1 | Trabeculectomy |
| 1 | Tonometry, Ocular |
| 1 | Tobacco Use Cessation Products |
| 1 | Tissue and Organ Procurement |
| 1 | Time-to-Treatment |
| 1 | Thymocytes |
| 1 | Thrombosis |
| 1 | Thinking |
| 1 | Therapeutic Equipoise |
| 1 | Thalamus |
| 1 | Tetrodotoxin |
| 1 | Tertiary Care Centers |
| 1 | Teriparatide |
| 1 | Terfenadine |
| 1 | Teaching |
| 1 | Tandem Mass Spectrometry |
| 1 | Tachycardia |
| 1 | Tablets |
| 1 | T-Lymphocytes |
| 1 | Systole |
| 1 | Symptom Assessment |
| 1 | Survivors |
| 1 | Survival |
| 1 | Surgical Wound Infection |
| 1 | Surgical Flaps |
| 1 | Succinylcholine |
| 1 | Subtilisins |
| 1 | Substance-Related Disorders |
| 1 | Students, Dental |
| 1 | Structure-Activity Relationship |
| 1 | Stiff-Person Syndrome |
| 1 | Sterilization |
| 1 | Stents |
| 1 | Stearic Acids |
| 1 | Staining and Labeling |
| 1 | Staff Development |
| 1 | Spinal Neoplasms |
| 1 | Spinal Cord |
| 1 | Spatio-Temporal Analysis |
| 1 | Space Perception |
| 1 | Software |
| 1 | Societies, Scientific |
| 1 | Social Skills |
| 1 | Social Media |
| 1 | Smoking Cessation |
| 1 | Sleep Disorders, Circadian Rhythm |
| 1 | Skull Base |
| 1 | Sirtuin 1 |
| 1 | Signal Processing, Computer-Assisted |
| 1 | Signal Detection, Psychological |
| 1 | Siderophores |
| 1 | Siblings |
| 1 | Shock |
| 1 | Shock, Hemorrhagic |
| 1 | Sex Distribution |
| 1 | Sex Determination Processes |
| 1 | Sex Chromosomes |
| 1 | Serotonin Plasma Membrane Transport Proteins |
| 1 | Sequence Deletion |
| 1 | Sequence Analysis, RNA |
| 1 | Sepsis |
| 1 | Self-Assessment |
| 1 | Self Report |
| 1 | Secretory Vesicles |
| 1 | Secretory Pathway |
| 1 | Scleroderma, Systemic |
| 1 | Sample Size |
| 1 | Salivary Ducts |
| 1 | Safety |
| 1 | SMARCB1 Protein |
| 1 | Ryanodine Receptor Calcium Release Channel |
| 1 | Rilpivirine |
| 1 | Ricinoleic Acids |
| 1 | Ribosomal Protein S6 Kinases |
| 1 | Ribosomal Protein S6 Kinases, 90-kDa |
| 1 | Rhinitis, Allergic |
| 1 | Rhinitis, Allergic, Seasonal |
| 1 | Rhinitis, Allergic, Perennial |
| 1 | Rheumatic Diseases |
| 1 | Reverse Transcriptase Polymerase Chain Reaction |
| 1 | Respiration, Artificial |
| 1 | Resource Allocation |
| 1 | Research |
| 1 | Reperfusion |
| 1 | Reperfusion Injury |
| 1 | Reoperation |
| 1 | Renal Replacement Therapy |
| 1 | Renal Insufficiency |
| 1 | Renal Insufficiency, Chronic |
| 1 | Reinforcement (Psychology) |
| 1 | Regression Analysis |
| 1 | Reference Values |
| 1 | Recurrence |
| 1 | Recovery of Function |
| 1 | Receptors, Tumor Necrosis Factor |
| 1 | Receptors, Steroid |
| 1 | Receptors, Glycine |
| 1 | Receptors, Antigen, B-Cell |
| 1 | Receptor, Serotonin, 5-HT2A |
| 1 | Receptor, Serotonin, 5-HT1A |
| 1 | Receptor, Epidermal Growth Factor |
| 1 | Rats, Wistar |
| 1 | Radiotherapy, High-Energy |
| 1 | Radiotherapy Dosage |
| 1 | Radiosurgery |
| 1 | Radio Waves |
| 1 | RNA, Viral |
| 1 | RNA, Messenger |
| 1 | Quinolones |
| 1 | Quantitative Trait Loci |
| 1 | Quality-Adjusted Life Years |
| 1 | Quality Control |
| 1 | Quality Assurance, Health Care |
| 1 | Qualitative Research |
| 1 | Quadriceps Muscle |
| 1 | Pyrimidines |
| 1 | Pyrazines |
| 1 | Pulmonary Medicine |
| 1 | Public Health |
| 1 | Psychotropic Drugs |
| 1 | Psychotherapy |
| 1 | Psychomotor Performance |
| 1 | Psychometrics |
| 1 | Pruritus |
| 1 | Proto-Oncogene Proteins pp60(c-src) |
| 1 | Proteomics |
| 1 | Proteolysis |
| 1 | Proteoglycans |
| 1 | Proteinuria |
| 1 | Protein-Lysine 6-Oxidase |
| 1 | Protein Structure, Secondary |
| 1 | Protein Processing, Post-Translational |
| 1 | Protein Multimerization |
| 1 | Protein Kinase C |
| 1 | Protein Isoforms |
| 1 | Protein Carbonylation |
| 1 | Protein Aggregates |
| 1 | Promoter Regions, Genetic |
| 1 | Programmed Cell Death 1 Receptor |
| 1 | Program Development |
| 1 | Presynaptic Terminals |
| 1 | Premature Birth |
| 1 | Pregnancy Outcome |
| 1 | Prefrontal Cortex |
| 1 | Pre-Eclampsia |
| 1 | Practice Patterns, Physicians' |
| 1 | Postmenopause |
| 1 | Population Surveillance |
